ArticleNPJ digital medicine2026
LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluation Methods for Inference-Time Retrieval-Augmented and Graph Retrieval-Augmented Large Language Models in Health Care: Scoping Review.Journal of medical Internet research · 2026Article
- Performance comparison of large language models for medication counseling in people living with HIV.Frontiers in public health · 2026Article
- Precision oncology: from large language models to multi-agent systems.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Due to its multi-factor mechanism, variable opioid response, and high-risk adverse reactions, cancer pain remains a major challenge in oncology. To overcome these obstacles, we have developed a collaboration framework based on large language models (LLMs): OncoPainBot. This framework can simulate the reasoning and decision-making of multiple clinical experts to conduct comprehensive cancer pain assessment and management. Our OncoPainBot integrates four specialized agents: Pain-Extraction, Pain-Mechanism Reasoning, Treatment-Planning, and Safety-Check, each corresponding to a unique clinical role. In this paper, we compare seven LLMs and three Retrieval-Augmented Generation(RAG) strategies to determine the optimal model configuration. The final framework was verified on 516 real-world electronic medical records of cancer pain collected. We tested our solution through multiple dimensions. Ultimately, Claude-4 combined with RAG achieved the best overall performance, demonstrating outstanding semantic consistency and evidence-based reasoning in multiple metrics. In clinical validation, OncoPainBot achieved a high degree of consistency between the generated reports and actual clinical documents, while maintaining a high decision-making accuracy (0.841) in the analgesic recommendation task. At the same time, our error analysis shows that most of the differences are caused by patient-specific factors and monitoring recommendations rather than incorrect drug selection, which demonstrates the reliability of our framework. OncoPainBot has demonstrated the feasibility of a cancer pain management system based on LLMs, providing a transparent, evidence-based, and clinical-based framework for personalized analgesic care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.